3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
3
Breast Neoplasms
3
Squamous Cell Carcinoma of Head and Neck
1
Recurrent Metastatic Non-Squamous Non Small Cell Lung Cancer
1
Recurrence
1
Patient Preference
1
Neoplasms
1
Lymphoma, Non-Hodgkin
1
Inflammatory Breast Neoplasms
1
Colorectal Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
CD20-positive Hematological Malignancies
1
Bile Duct Neoplasms
1
Advanced Cancers
1
Interventions
pembrolizumab
25
Cisplatin
20
Carboplatin
14
Paclitaxel
11
Radiotherapy
9
Radiotherapy, Intensity-Modulated
8
Docetaxel
8
Cetuximab
8
Nivolumab
6
cemiplimab
5
Radiation
5
durvalumab
4
atezolizumab
3
Taxes
3
Surveys and Questionnaires
3
Fluorouracil
3
Drug Therapy
3
Cyclophosphamide
3
Blood Specimen Collection
3
toripalimab
2
olaparib
2
fludarabine
2
avelumab
2
alpha-2'-deoxythioguanosine
2
aldesleukin
2
Surgical Procedures, Operative
2
Standard of Care
2
Pemetrexed
2
Magnetic Resonance Spectroscopy
2
vistusertib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Squamous Cell
×
Injections, Subcutaneous
×
1 year
×
Clear all
No trials found.